Cargando…
Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission
BACKGROUND: 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a potent serotonin (5-HT) receptor agonist with hallucinogenic properties. The aim of our research was to examine the role of the 5-HT(2A), 5-HT(2C) and 5-HT(1A) serotonin receptor subtypes in 25I-NBOMe hallucinogenic...
Autores principales: | Herian, Monika, Wojtas, Adam, Sobocińska, Małgorzata Katarzyna, Skawski, Mateusz, González-Marín, Alejandro, Gołembiowska, Krystyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704505/ https://www.ncbi.nlm.nih.gov/pubmed/33174181 http://dx.doi.org/10.1007/s43440-020-00181-4 |
Ejemplares similares
-
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2021) -
Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats
por: Wojtas, Adam, et al.
Publicado: (2020) -
Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2022) -
Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats
por: Herian, Monika, et al.
Publicado: (2019) -
Chronic psychosis associated with new hallucinogenic drug 25I-NBOMe
por: Martin-Santiago, O., et al.
Publicado: (2023)